NEW YORK (GenomeWeb News) – Molecular diagnostics Co-Diagnostics late on Friday announced an agreement with DNA Logix to acquire certain technologies for genetic analysis in the clinical, industrial, and biothreat spaces.

Sandy, Utah-based Co-Diagnostics will buy DNA Logix's technology pertaining to DNA testing with "superior sensitivity and specificity. The technology facilitates rapid assay development and significantly reduced costs for the end user," it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.